Drug intelligence / Profile preview

methyl 3-chloro-2-{3-[(2,5-dihydroxy-4-methoxyphenyl)amino]-3-oxopropyl}-4,6-dihydroxybenzoate

Development stage
Unknown
Modality
Small Molecules
01

Overview

Methyl 3-chloro-2-{3-[(2,5-dihydroxy-4-methoxyphenyl)amino]-3-oxopropyl}-4,6-dihydroxybenzoate is a synthetic small molecule belonging to the class of p-hydroxybenzoic acid alkyl esters. It has a molecular formula of C18H18ClNO8 and a molecular weight of approximately 411.8 g/mol[1][2]. The compound is considered experimental and is not approved for clinical use in any country[2]. Its primary known biological activity is as an inhibitor of heat shock protein HSP90-beta (HSP90AB1), suggesting potential utility in modulating protein folding and stress response pathways relevant to cancer or other diseases involving proteostasis[2]. No marketed products or clinical indications are currently associated with this compound.

Other names
methyl 3-chloro-2-(3-((2,5-dihydroxy-4-methoxyphenyl)amino)-3-oxopropyl)-4,6-dihydroxybenzoatemethyl 3-chloro-2-{2-[(2,5-dihydroxy-4-methoxyphenyl)carbamoyl]ethyl}-4,6-dihydroxybenzoate
02

Targets

HSP90AB1 (Heat shock protein HSP 90-beta)

Beyond the preview

Go deeper on methyl 3-chloro-2-{3-[(2,5-dihydroxy-4-methoxyphenyl)amino]-3-oxopropyl}-4,6-dihydroxybenzoate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methyl 3-chloro-2-{3-[(2,5-dihydroxy-4-methoxyphenyl)amino]-3-oxopropyl}-4,6-dihydroxybenzoate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call